Rao Madduri Ravin 4
4 · Aeglea BioTherapeutics, Inc. · Filed Nov 4, 2019
Insider Transaction Report
Form 4
Rao Madduri Ravin
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-11-01+130,000→ 130,000 totalExercise: $8.24Exp: 2029-10-31→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]The options will vest as to 1/4th of the total shares on November 1, 2020, and then 1/48th of the shares monthly thereafter, such that the option is fully vested on November 1, 2023, subject to the Reporting Person's provision of service to the issuer on each vesting date.